Association between pretreatment haemoglobin levels and morphometric characteristics of the tumour, response to neoadjuvant treatment and long-term outcomes in patients with locally advanced rectal cancers

Colorectal Disease

Volumn 15, Issue 10, 2013, Pages 1232-1237

  Khan, A A ^a   Klonizakis, M ^b   Shabaan, A ^c   Glynne Jones, R ^a  

^a Mount Vernon Cancer Treatment and Research Centre   (United Kingdom)

^b SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

^c MINIA UNIVERSITY HOSPITAL   (Egypt)

Author keywords

Chemoradiation; Haemoglobin; Neoadjuvant; Radiotherapy; Rectal carcinoma

Indexed keywords

CAPECITABINE; FLUOROPYRIMIDINE; FLUOROURACIL; FOLINIC ACID; HEMOGLOBIN; IRINOTECAN; MITOMYCIN; OXALIPLATIN; RALTITREXED;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CHEMORADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; PRIORITY JOURNAL; RECTUM CANCER; RECTUM CARCINOMA; TREATMENT OUTCOME; TREATMENT RESPONSE;

CHEMORADIATION; HAEMOGLOBIN; NEOADJUVANT; RADIOTHERAPY; RECTAL CARCINOMA;

ADENOCARCINOMA; AGED; ANEMIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY, ADJUVANT; DOSE FRACTIONATION; FEMALE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RECTAL NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84886310794     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/codi.12307     Document Type: Article

References (33)

1. Berardi R, Maccaroni E, Onofri A et al. Locally advanced rectal cancer: from molecular profiling to clinical practice. A literature review: part 2. Expert Opin Pharmacother [Review] 2009; 10: 2467-78.
2. van Halteren HK, Houterman S, Verheij CD, Lemmens VE, Coebergh JW. Anaemia prior to operation is related with poorer long-term survival in patients with operable rectal cancer. Eur J Surg Oncol [Research Support, Non-U.S. Gov't] 2004; 30: 628-32.
3. Rades D, Kuhn H, Schultze J et al. Prognostic factors affecting locally recurrent rectal cancer and clinical significance of hemoglobin. Int J Radiat Oncol Biol Phys 2008; 70: 1087-93.
4. Yoon SM, Kim DY, Kim TH et al. Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 2007; 69: 1167-72.
5. Box B, Lindsey I, Wheeler JM et al. Neoadjuvant therapy for rectal cancer: improved tumor response, local recurrence, and overall survival in nonanemic patients. Dis Colon Rectum 2005; 48: 1153-60.
6. Raje D, Mukhtar H, Oshowo A, Ingham Clark C. What proportion of patients referred to secondary care with iron deficiency anemia have colon cancer? Dis Colon Rectum 2007; 50: 1211-4.
7. Lee SD, Park JW, Park KS et al. Influence of anemia on tumor response to preoperative chemoradiotherapy for locally advanced rectal cancer. Int J Colorectal Dis 2009; 24: 1451-8.
8. Vaupel P, Thews O, Mayer A, Hockel S, Hockel M. Oxygenation status of gynecologic tumors: what is the optimal hemoglobin level? Strahlenther Onkol 2002; 178: 727-31.
9. Harrison LB, Chadha M, Hill RJ, Hu K, Shasha D. Impact of tumor hypoxia and anemia on radiation therapy outcomes. Oncologist 2002; 7: 492-508.
10. Vaupel P, Mayer A, Hockel M. Impact of hemoglobin levels on tumor oxygenation: the higher, the better? Strahlenther Onkol [Research Support, Non-U.S. Gov't Review] 2006; 182: 63-71.
11. Quirke P, Steele R, Monson J et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet [Research Support, Non-U.S. Gov't] 2009; 373: 821-8.
12. Glynne-Jones R, Wallace M, Livingstone JI, Meyrick-Thomas J. Complete clinical response after preoperative chemoradiation in rectal cancer: is a "wait and see" policy justified? Dis Colon Rectum [Review] 2008; 51: 10-9; discussion 9-20.
13. Chen MH, Chang PM, Chen PM et al. Prognostic significance of a pretreatment hematologic profile in patients with head and neck cancer. J Cancer Res Clin Oncol [Research Support, Non-U.S. Gov't] 2009; 135: 1783-90.
14. Kandemir EG, Mayadagli A, Turken O, Yaylaci M, Ozturk A. Pre-treatment haemoglobin concentration is a prognostic factor in patients with early-stage breast cancer. J Int Med Res 2005; 33: 319-28.
15. Krzystek-Korpacka M, Matusiewicz M, Diakowska D et al. Even a mild anemia is related to tumor aggressiveness mediated by angiogenic factors. Exp Oncol 2009; 31: 52-6.
16. Park SH, Lee J, Lee SH et al. Anemia is the strongest prognostic factor for outcomes of 5-fluorouracil-based first-line chemotherapy in patients with advanced gastric cancer. Cancer Chemother Pharmacol 2006; 57: 91-6.
17. Grigiene R, Valuckas KP, Aleknavicius E, Kurtinaitis J, Letautiene SR. The value of prognostic factors for uterine cervical cancer patients treated with irradiation alone. BMC Cancer 2007; 7: 234.
18. Yurut-Caloglu V, Caloglu M, Kaplan M, Inci O. Pre-treatment hemoglobin levels are important for bladder carcinoma patients with extravesical extension undergoing definitive radiotherapy. Asian Pac J Cancer Prev 2009; 10: 1151-7.
19. Dunne JR, Gannon CJ, Osborn TM, Taylor MD, Malone DL, Napolitano LM. Preoperative anemia in colon cancer: assessment of risk factors. Am Surg 2002; 68: 582-7.
20. Martin-Loeches M, Orti RM, Cazorla E, Asins E, Llixiona J. Multivariate analysis of the morphometric characteristics of tumours as prognostic factors in the survival of patients with uterine cervix cancer treated with radical surgery. Eur J Obstet Gynecol Reprod Biol 2002; 105: 170-6.
21. Morikawa T, Tanaka N, Kuchiba A et al. Predictors of lymph node count in colorectal cancer resections: data from US Nationwide Prospective Cohort Studies. Arch Surg 2012; 147: 715-23.
22. Targarona EM, Balague C, Pernas JC et al. Can we predict immediate outcome after laparoscopic rectal surgery? Multivariate analysis of clinical, anatomic, and pathologic features after 3-dimensional reconstruction of the pelvic anatomy. Ann Surg 2008; 247: 642-9.
23. Vaupel P, Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 2007; 26: 225-39.
24. Nordsmark M, Bentzen SM, Rudat V et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol 2005; 77: 18-24.
25. Hockel M, Knoop C, Schlenger K et al. Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 1993; 26: 45-50.
26. Nordsmark M, Alsner J, Keller J et al. Hypoxia in human soft tissue sarcomas: adverse impact on survival and no association with p53 mutations. Br J Cancer 2001; 84: 1070-5.
27. Dunst J, Becker A, Lautenschlager C et al. Anemia and elevated systemic levels of vascular endothelial growth factor (VEGF). Strahlenther Onkol 2002; 178: 436-41.
28. Vaupel P, Thews O, Hoeckel M. Treatment resistance of solid tumors: role of hypoxia and anemia. Med Oncol 2001; 18: 243-59.
29. Hoff CM. Importance of hemoglobin concentration and its modification for the outcome of head and neck cancer patients treated with radiotherapy. Acta Oncol 2012; 51: 419-32.
30. Heiss MM, Mempel W, Jauch KW et al. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet [Clinical Trial Comparative Study Randomized Controlled Trial Research Support, Non-U.S. Gov't] 1993; 342: 1328-33.
31. Glaspy J, Crawford J, Vansteenkiste J et al. Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes. Br J Cancer [Meta-Analysis] 2010; 102: 301-15.
32. Sheikh S, Littlewood TJ. Erythropoiesis-stimulating agents for anemic patients with cancer. Expert Rev Hematol [Review] 2010; 3: 697-704.
33. Graf W, Bergstrom R, Pahlman L, Glimelius B. Appraisal of a model for prediction of prognosis in advanced colorectal cancer. Eur J Cancer 1994; 30A: 453-7.